A Pedigree-Based Prediction Model Identifies Carriers of Deleterious De Novo Mutations in Families With Li-Fraumeni Syndrome

doi 10.1101/2020.02.10.942409
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Cancer Phenotype Correlates With Constitutional TP53 Genotype in Families With the Li–Fraumeni Syndrome

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Breast Cancer Phenotype in Women With TP53 Germline Mutations: A Li-Fraumeni Syndrome Consortium Effort

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

P53 Therapy in a Patient With Li-Fraumeni Syndrome

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Li-Fraumeni Syndrome: A P53 Family Affair

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2005English

Inhibiting Mitochondrial Respiration Prevents Cancer in a Mouse Model of Li-Fraumeni Syndrome

Journal of Clinical Investigation
Medicine
2016English

Genetic Modeling of Li-Fraumeni Syndrome in Zebrafish

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2010English

Radiation-Induced G1 Arrest Is Not Defective in Fibroblasts From Li-Fraumeni Families Without TP53 Mutations

British Journal of Cancer
Cancer ResearchOncology
1999English

Li-Fraumeni Syndrome – A Molecular and Clinical Review

British Journal of Cancer
Cancer ResearchOncology
1997English

TP53 (Tumour Protein P53 (Li-Fraumeni Syndrome))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy